 |
1C5W |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5X |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5Y |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5Z |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1D3P |
CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3 |
A |
B |
|
|
 |
1G37 |
CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE |
B |
A |
Trypsin-like serine proteases |
|
 |
1GI7 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI8 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI9 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GJ4 |
SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
L |
H |
|
|
 |
1ID5 |
CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN |
L |
H |
|
|
 |
1MKW |
THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING |
L |
H |
|
|
 |
1MKX |
THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING |
L |
H |
|
|
 |
1NZQ |
D-Phe-Pro-Arg-Type Thrombin Inhibitor |
L |
H |
|
|
 |
1O3P |
Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors |
A |
B |
|
|
 |
1O5A |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5B |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5C |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5G |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
L |
H |
|
|
 |
1QBV |
CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE-MIMETIC INHIBITOR |
L |
H |
|
|
 |
1RIW |
Thrombin in complex with natural product inhibitor Oscillarin |
D |
B |
|
|
 |
1SG8 |
Crystal structure of the procoagulant fast form of thrombin |
A |
B |
|
|
 |
1SGI |
Crystal structure of the anticoagulant slow form of thrombin |
D |
E |
|
|
 |
1TWX |
Crystal structure of the thrombin mutant D221A/D222K |
A |
B |
|
|
 |
1UVT |
BOVINE THROMBIN--BM14.1248 COMPLEX |
L |
H |
|
|
 |
1VR1 |
Specifity for Plasminogen Activator Inhibitor-1 |
L |
H |
|
|
 |
1W7G |
ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54-65) AND L-ARGININE TEMPLATE INHIBITOR CS107 |
L |
H |
|
|
 |
1YCP |
THE CRYSTAL STRUCTURE OF FIBRINOGEN-AA PEPTIDE 1-23 (F8Y) BOUND TO BOVINE THROMBIN EXPLAINS WHY THE MUTATION OF PHE-8 TO TYROSINE STRONGLY INHIBITS NORMAL CLEAVAGE AT ARGININE-16 |
L |
H |
|
|
 |
1YPE |
Thrombin Inhibitor Complex |
L |
H |
|
|
 |
1YPG |
Thrombin Inhibitor Complex |
L |
H |
|
|
 |
1YPJ |
Thrombin Inhibitor Complex |
L |
H |
|
|
 |
1YPK |
Thrombin Inhibitor Complex |
L |
H |
|
|
 |
1YPL |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1008 |
L |
H |
|
|
 |
1YPM |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1014 |
L |
H |
|
|
 |
2C8W |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2C8X |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2C8Y |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2C8Z |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2C90 |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2C93 |
THROMBIN INHIBITORS |
A |
B |
|
|
 |
2GDE |
Thrombin in complex with inhibitor |
L |
H |
|
|
 |
2H9T |
Crystal structure of human alpha-thrombin in complex with suramin |
L |
H |
|
|
 |
2HWL |
Crystal structure of thrombin in complex with fibrinogen gamma\' peptide |
A |
B |
|
|
 |
2JH0 |
HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX. |
C |
D |
|
|
 |
2JH5 |
HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX. |
C |
D |
|
|
 |
2JH6 |
HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX. |
C |
D |
|
|
 |
2PW8 |
Crystal structure of sulfo-hirudin complexed to thrombin |
L |
H |
|
|
 |
2R2M |
2-(2-Chloro-6-Fluorophenyl)Acetamides as Potent Thrombin Inhibitors |
H |
B |
|
|
 |
2UUF |
THROMBIN-HIRUGEN BINARY COMPLEX AT 1.26A RESOLUTION |
A |
B |
|
|
 |
2UUJ |
THROMBIN-HIRUGEN-GW473178 TERNARY COMPLEX AT 1.32A RESOLUTION |
A |
B |
|
|